It ranked among the top 10 S&P 500 performers with an . Biotech and Healthcare Breakthroughs
For long-term stability, analysts highlighted established leaders pivoting into new growth markets. Vertex Pharmaceuticals
Revenues were projected to triple, supporting its in 2017. best stocks to buy right now 2017
: Capitalized on the e-commerce boom and rising digital transaction volumes.
: The Invisalign maker dominated the orthodontic market, reaching record annual sales. It was one of the year's top performers with a 131% return . It ranked among the top 10 S&P 500 performers with an
: Benefited from explosive demand for graphics chips in data centers and artificial intelligence. The stock ended the year with an 81% gain .
: Surged due to rising prices and high demand for memory chips (DRAM and NAND). : Capitalized on the e-commerce boom and rising
Significant R&D payoffs led to massive gains for select pharmaceutical and health-tech companies.